Renounceable Right

(redirected from Renounceable Rights)

Renounceable Right

A right attached to a security that one may buy or sell separately from that security. The right is usually the ability to buy more shares in a publicly-traded company at a discount, especially after a new issue of stock that would otherwise dilute the stockholder's holding. If one sells a renounceable right, its buyer receives this ability. It differentiates from a nonrenounceable right, which always must remain attached to the security with which it was originally issued.
Mentioned in ?
References in periodicals archive ?
There are two types of rights issue, renounceable rights and non-renounceable rights.
Selling a Rights Issue: Offering Flexibility to Shareholders and a Corporate Financing Tool in Qatar
39 million based on the indicative issue price of 10 sen per renounceable rights share.
Borneo Oil gets nod for issue
1m of the total amount to be raised in the pro-rata renounceable rights issue.
-Patersons Securities to run Panax Geothermal's rights issue
IEF shareholders are being asked to take part in a two-for-one pro-rata renounceable rights issue as part of a range of initiatives being undertaken by the fund to reduce debt levels.
New Zealand : Van Eyk Three Pillars buys up ING pub fund
36 per share to raise AUD9m and one for five renounceable rights issue at USD0.
Adamus plans capital raise of up to AUD30.5m
2bn renounceable rights offering at a discount of 46.
China Merchants Bank sets rights issue at a discount
Sydney, Australia, June 29, 2007 - (JCN Newswire) - IBA Health Limited (ASX: IBA) - Australia's largest listed eHealth company, today announced today that following the closing of its 2 for 5 renounceable rights issue, acceptances were received for 137,726,782 New Shares.
IBA Health Successfully Raises A$145.4 Million Through Rights Issue
The company recently made a one for eight renounceable rights issue.
Should you, could you, would you list your company? (Lead Feature)
MELBOURNE, Australia -- Benitec Ltd (ASX:BLT), a world leader in RNA-based gene silencing for human therapeutics, today announced its fully underwritten AU$8 million renounceable rights issue, incorporating an entitlement offer and a shortfall offer, had successfully closed oversubscribed.
Benitec Raises AU$8 million to Forge Ahead with its Gene Silencing Therapeutics: Rights Issue Closes Oversubscribed
The Prior Announcement advised that the Company was contemplating undertaking a renounceable rights issue on the basis of 2 new shares for every 1 share held at a price of AUD$0.
Buccaneer Energy Limited (ASX:BCC) Recapitalisation Process
Release date- 14112009 - CAL Bank Ltd is pleased to announce the successful completion of its renounceable Rights Issue.
PRESS RELEASE-CAL BANK SUCCESFULLY COMPLETES ITS RIGHTS ISSUE
The sales were made pursuant to the Prospectus dated 2nd September 2009, originally used for the Company's Renounceable Rights Issue that closed on 6th October 2009.
Samson Oil & Gas Announces Final Placement of Shares and Options from October 2009 Rights Offering

Financial browser ?
Full browser ?